Basilea Pharmaceutica Ltd. announces that Toctino (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema unresponsive to potent topical corticosteroids, has been approved by the Dutch Medicines Evaluation Board.
The details can be read here.
No comments:
Post a Comment